期刊文献+

半夏泻心汤改善伊立替康致小细胞肺癌荷瘤鼠脾虚的作用 被引量:4

Study on Improvement of Banxia Xiexin Decoction against Irinotecan-induced Spleen Deficiency of Tumor-Bearing Mice with Small-cell Lung Cancer
原文传递
导出
摘要 目的:观察半夏泻心汤对伊立替康(Irinotecan,CPT-11)致于小细胞肺癌(Small-cell lung cancer,SCLC)荷瘤鼠脾虚的改善作用。方法:取荷瘤鼠,按高、中、低剂量灌胃给予半夏泻心汤,对照组给水,连续8天,第3天开始尾静脉注射CPT-11,连续4天,观察荷瘤鼠全身情况及活动能力、体重及腹泻,第8天眼球取血,酶联免疫吸附法(Enzyme-linked immunosorbent assay,EL ISA)测定血清中胃泌素含量。结果:空白组荷瘤鼠活动能力下降,半夏泻心汤给药组荷瘤鼠活动能力有明显改善,体重下降减缓,并能减少腹泻的发生,但对血清胃泌素的影响无统计学差异。结论:半夏泻心汤对CPT-11作用于SCLC荷瘤鼠后的脾虚具有改善作用。 Objective: To observe the improvement of Banxia Xiexin Decoction against irinotecan -induced (CPT - 11 )spleen deficiency of tumor- bearing mice with small -cell lung cancer(SCLC). Methods: Banxia Xiexin Decoction was administered to mice for eight days. CPT - 11 was given from the 3rd day to the 6th day. The activity, weight and di- arrhea of each mouse were recorded. Enzyme - linked immunosorbent assay ( ELISA ) was used to analyze the concentra- tions of gastrin in blood which was obtained from eyeballs at the 8th day. Results : The activity of the blank group was weaker than that of other three groups. The body weight increase both in the high and low dose group was more than that of the blank group from the 1st day to the $th day. The diarrhea in the administrated groups was better than the that in the blank group. There were no significant differences of the gastrin concentrations between each administrated group and the blank group. Conclusion: Banxia Xiexin Decoction could improve the spleen deficiency induced by CPT - 11 in nude mice bearing the tumor of SCLC.
出处 《中华中医药学刊》 CAS 2012年第6期1313-1314,共2页 Chinese Archives of Traditional Chinese Medicine
基金 浙江省中医药科技计划项目(2010ZB006)
关键词 半夏泻心汤 伊立替康 脾虚 Banxia Xiexin Decoction irinotecan spleen deficiency
  • 相关文献

参考文献8

二级参考文献24

  • 1付剑江,李燕,李洪燕,刘悦,陈晓光.氧合酶-2抑制剂celecoxib与喜树碱类衍生物联合用药的实验研究[J].世界华人消化杂志,2005,13(16):1985-1991. 被引量:6
  • 2姜宏宇,王冠军,丁艳华.低剂量X射线照射对荷人小细胞肺癌(NCI-H446)裸小鼠移植瘤细胞凋亡相关基因mRNA表达的影响[J].中国老年学杂志,2005,25(11):1373-1375. 被引量:7
  • 3卢红阳,马胜林,张沂平.依立替康在肺癌中的应用[J].实用肿瘤杂志,2006,21(3):276-279. 被引量:3
  • 4涂福音,曾志德,吴耀南,吴健朗,张琼英,常虹.慢性萎缩性胃炎103例中医证型与血清胃泌素、尿胃蛋白酶关系探讨[J].福建中医药,1990,21(2):11-12. 被引量:14
  • 5Govindan R,Page N,Morgensztern D,et al. Changing epidemiology of small cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database [J]. J Clin Oncol,2006,24(28) :,1539-4544.
  • 6Noda K,Nishiwaki Y,Kawahara M,et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small cell lung cancer [J]. N Engl J Med, 2002,346 (2) : 85- 91.
  • 7Hanna NH,Einhorn L,Sandler A,et al. Randomized, phase Ⅲ trial comparing irinotecan/cisplatin(IP) with etoposide/cisplatin (EP) in patients with previously untreated,extensive-stage (ES) small cell lung cancer (SCLC) [J]. J Clin Oncol,2005,16(5):622.
  • 8Akinobu K, Kado S, Kaneda N, et al. Modified irinotecan hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats [J]. Cancer Chemother Pharmacol, 2000, 46 (3):211-220.
  • 9Chiu CJ, McArdle AH, Brown R, et al. Intestinal mucosal lesion in low flow states [J]. Arch Surg, 1970,101 (4): 478- 485.
  • 10Kurita A, Kado S, Kaneda N, et al. Modified irinoteean hydrochloride (CPT-11) administration schedule improves induction of delayed-onset diarrhea in rats [J]. Cancer Chemother Pharmacol, 2000,46 (3) : 211 - 220.

共引文献58

同被引文献97

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部